بدائل البحث:
greatest decrease » treatment decreased (توسيع البحث), greater increase (توسيع البحث)
lasso decrease » largest decrease (توسيع البحث)
set decrease » step decrease (توسيع البحث), sizes decrease (توسيع البحث), mean decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
يعرض 1 - 20 نتائج من 348 نتيجة بحث عن '(( third ((((set decrease) OR (greatest decrease))) OR (we decrease)) ) OR ( via lasso decrease ))', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    The red blood cell-platelet ratio affects prognosis.

    The red blood cell-platelet ratio affects prognosis. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization.

    Red blood cell-platelet ratio and HR-restriction cube diagram during hospitalization. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Correlation analysis of red blood cell-platelet ratio and coagulation indicators.

    Correlation analysis of red blood cell-platelet ratio and coagulation indicators. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    State transition dynamics of reputation considering third-order information and multiple reputation values:

    State transition dynamics of reputation considering third-order information and multiple reputation values: حسب Hitoshi Yamamoto (738861)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. However, M:D FMT products exhibited the smallest median loss of bacterial viability following lyophilization and outperforms other lyopreservatives. Data is represented as median and range in parentheses. Significant p-values are bolded. Abbreviations: C, centrifuged; NC, not centrifuged; MD, maltodextrin and trehalose.

    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the g... حسب Nina K. Randolph (21030732)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Validation of child labor measures using third-party data, households with all children in school.

    Validation of child labor measures using third-party data, households with all children in school. حسب Guilherme Lichand (11410286)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx

    Table 2_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Evaluation rule considering third-order information and multiple reputation values: By cluster analysis and best-fitting distribution for each distribution done on basis of BIC, reputation values are classified as good, bad, and neutral.

    Evaluation rule considering third-order information and multiple reputation values: By cluster analysis and best-fitting distribution for each distribution done on basis of BIC, re... حسب Hitoshi Yamamoto (738861)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Flow chart describing samples.

    Flow chart describing samples. حسب Rabi Joël Gansaonré (20416803)

    منشور في 2024
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Univariate analysis of hospitalized patients.

    Univariate analysis of hospitalized patients. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization.

    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM.

    Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Clinical baseline data.

    Clinical baseline data. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Univariate analysis of ICU patients.

    Univariate analysis of ICU patients. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay.

    Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. حسب Jie Zhao (49409)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: